Sort
8,912 grants matching “sars cov 2”
Low Cardiorespiratory Fitness and Chronotropic Incompetence inHIV: Risk Factors, Cardiovascular Implications, and Exercise Training as Treatment
$197,748Matthew Durstenfeld · University Of California, San Francisco · K23 · FY2024 · HL
Low Cardiorespiratory Fitness and Chronotropic Incompetence inHIV: Risk Factors, Cardiovascular Implications, and Exercise Training as Treatment
$197,748Matthew Durstenfeld · University Of California, San Francisco · K23 · FY2025 · HL
RAPID: Microelectrode Array Sensors for SARS-CoV-2 and Other RNA Viruses
$197,558Gangli Wang · Georgia State University Research Foundation, Inc. · · FY2020 · MPS
Development of reverse genetic systems and mouse model for SARS-CoV-2
$197,500Ricardo Rajsbaum · University Of Texas Med Br Galveston · R01 · FY2020 · AI
mRNA COVID-19 Vaccines Delivered with Plant Virus/Polymer Devices
$197,500Nicole Franziska Steinmetz · University Of California, San Diego · R21 · FY2022 · AI
A Helminth-Derived Immune Potentiator for Biodefense
$197,500Sara Lustigman · New York Blood Center · R21 · FY2006 · AI
Development of reverse genetic systems and mouse model for SARS-CoV-2
$197,500Ricardo Rajsbaum · University Of Texas Med Br Galveston · R01 · FY2021 · AI
Quadruple-resonance HFXY 1.3 mm CP-MAS probe for a solid-state NMR wide-bore magnet
$197,485Mei Hong · Massachusetts Institute Of Technology · R01 · FY2023 · GM
RAPID COVID-19 DCL response: Wastewater Pathogen Tracking Dashboard
$197,375Rachel R Spurbeck · Battelle Memorial Institute · · FY2020 · BIO
Clinical subjects and recruitment
$197,364Albert C Shaw · Yale University · U19 · FY2024 · AI
Spatiotemporal Mechanisms of Olfactory Processing in the Human Brain
$197,357Jay A Gottfried · University Of Pennsylvania · R01 · FY2020 · DC
Deciphering the Molecular Mechanisms of Response to COVID Vaccine in Kidney Transplant Recipients
$197,333Jonathan S Maltzman · Palo Alto Veterans Instit For Research · R21 · FY2024 · AI
Clinical and Biological Predictors of Delirium and Long-term Cognitive Outcomes in COVID19 Patients
$197,204Esther Seunghee Oh · Johns Hopkins University · R01 · FY2021 · AG
SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD (SPIROMICS) III - SPIROMICS - TASK AREA B
$197,163Prescott G Woodruff · University Of California, San Francisco · N01 · FY2025 · HL
RAPID:NSF-BSF: Analysis of the spreading patterns and the efficiency of quarantine measures for COVID-19, based on available world-wide spatio-temporal data
$197,100Lazaros Gallos · Rutgers University New Brunswick · · FY2020 · BIO
Identifying existing, FDA-approved drugs with clinically protective effects against coronavirus disease 2019 using a big data approach
$196,995Josh Lambert · University Of Cincinnati · R21 · FY2022 · LM
E-PROOF: E-intervention for Protein Intake and Resistance Training to Optimize Function
$196,875Jessica L. Krok-Schoen · Ohio State University · R21 · FY2024 · AG
Therapy for long-COVID in a preclinical model
$196,875Daniel Kaufman · University Of California Los Angeles · R21 · FY2025 · AI
Impact of SARS-Cov-2 on a Rat Model Cerebral Amyloid Angiopathy
$196,875William E. Van Nostrand · University Of Rhode Island · R21 · FY2024 · AG
Regulation of Cell Death and Inflammation by ISG15 during SARS-CoV2 Infection
$196,875Deborah J Lenschow · Washington University · R21 · FY2021 · AI
SELF-MASKED ALDEHYDES AS INHIBITORS OF THE CYSTEINE PROTEASES 3CL PROTEASE, CATHEPSIN L, AND CRUZAIN
$196,856Thomas Meek · Texas A&M Agrilife Research · R21 · FY2023 · AI
Covalent inhibitors of host cell entry by SARS-CoV-2 for treatment of COVID-19
$196,750Matthew S Bogyo · Stanford University · R21 · FY2022 · AI
Obesity and COVID-19: Role of Adipose Tissue
$196,750Tracey McLaughlin · Stanford University · R21 · FY2022 · AI
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age
$196,732Maria Mori Brooks · University Of Pittsburgh At Pittsburgh · U19 · FY2021 · AG
The pathogenesis of COVID-19
$196,706Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI